Market Cap 3.86M
Revenue (ttm) 0.00
Net Income (ttm) -1.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.39
Volume 209,700
Avg Vol 59,836
Day's Range N/A - N/A
Shares Out 77.24M
Stochastic %K 0%
Beta 1.66
Analysts Strong Buy
Price Target $3.00

Company Profile

IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulce...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 655 5054
Address:
ZHR Industrial Zone, 20 Yahalom Street PO Box 143, Rosh Pinna, Israel
resx18
resx18 Jun. 30 at 12:45 PM
$IRME IRME video https://youtu.be/ojTfsUUTJNM?si=otfWxsQcgga6jcOm
0 · Reply
griffinrc23
griffinrc23 Jun. 25 at 1:51 PM
$IRME | OTCQB PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing tissue at risk for pressure injuries prior to visible skin breakdown IR-MED a developer of noninvasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, announces positive interim results from its ongoing U.S. clinical study of PressureSafe™, a handheld infrared spectroscopy device for assessment of pressure injuries (PIs), including deep tissue injuries (DTIs) before visible skin breakdown - a breakthrough especially significant for patients with darker skin tones https://marketwirenews.com/news-releases/ir-med-reports-positive-interim-results-from-u-s-cli-6790475701371317.html
0 · Reply
newsfile_corp
newsfile_corp Jun. 23 at 12:31 PM
https://nfne.ws/256006 $IRME #IRME #pressureinjury #pressuresafe #Chemicals #Biotechnology #HealthCare #Technology #OTC #OTCMarkets #OTCSto
0 · Reply
griffinrc23
griffinrc23 Jun. 2 at 2:11 PM
$IRME IR-Med Inc. DD IIR-Med, Inc. and its consolidated Subsidiary, IR. Med Ltd. is an innovative med-tech company focused on leveraging Infra-Red light for medical application. IR-MED Inc. is developing a cutting-edge infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices. The infrared spectroscopy technology allows harmless and non-invasive gathering of bio-information from patient blood and tissue. Read full $IRME DD: https://x.com/whiskey_lima729/status/1929525388671128024
0 · Reply
Latest News on IRME
No data available.
resx18
resx18 Jun. 30 at 12:45 PM
$IRME IRME video https://youtu.be/ojTfsUUTJNM?si=otfWxsQcgga6jcOm
0 · Reply
griffinrc23
griffinrc23 Jun. 25 at 1:51 PM
$IRME | OTCQB PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing tissue at risk for pressure injuries prior to visible skin breakdown IR-MED a developer of noninvasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, announces positive interim results from its ongoing U.S. clinical study of PressureSafe™, a handheld infrared spectroscopy device for assessment of pressure injuries (PIs), including deep tissue injuries (DTIs) before visible skin breakdown - a breakthrough especially significant for patients with darker skin tones https://marketwirenews.com/news-releases/ir-med-reports-positive-interim-results-from-u-s-cli-6790475701371317.html
0 · Reply
newsfile_corp
newsfile_corp Jun. 23 at 12:31 PM
https://nfne.ws/256006 $IRME #IRME #pressureinjury #pressuresafe #Chemicals #Biotechnology #HealthCare #Technology #OTC #OTCMarkets #OTCSto
0 · Reply
griffinrc23
griffinrc23 Jun. 2 at 2:11 PM
$IRME IR-Med Inc. DD IIR-Med, Inc. and its consolidated Subsidiary, IR. Med Ltd. is an innovative med-tech company focused on leveraging Infra-Red light for medical application. IR-MED Inc. is developing a cutting-edge infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices. The infrared spectroscopy technology allows harmless and non-invasive gathering of bio-information from patient blood and tissue. Read full $IRME DD: https://x.com/whiskey_lima729/status/1929525388671128024
0 · Reply